Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease
- PMID: 30446946
- DOI: 10.1007/s12035-018-1421-1
Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease
Abstract
Functional genomics applied to the study of RNA expression profiles identified several abnormal molecular processes in experimental prion disease. However, only a few similar studies have been carried out to date in a naturally occurring human prion disease. To better characterize the transcriptional cascades associated with sporadic Creutzfeldt-Jakob disease (sCJD), the most common human prion disease, we investigated the global gene expression profile in samples from the frontal cortex of 10 patients with sCJD and 10 non-neurological controls by microarray analysis. The comparison identified 333 highly differentially expressed genes (hDEGs) in sCJD. Functional enrichment Gene Ontology analysis revealed that hDEGs were mainly associated with synaptic transmission, including GABA (q value = 0.049) and glutamate (q value = 0.005) signaling, and the immune/inflammatory response. Furthermore, the analysis of cellular components performed on hDEGs showed a compromised regulation of vesicle-mediated transport with mainly up-regulated genes related to the endosome (q value = 0.01), lysosome (q value = 0.04), and extracellular exosome (q value < 0.01). A targeted analysis of the retromer core component VPS35 (vacuolar protein sorting-associated protein 35) showed a down-regulation of gene expression (p value= 0.006) and reduced brain protein levels (p value= 0.002). Taken together, these results confirm and expand previous microarray expression profile data in sCJD. Most significantly, they also demonstrate the involvement of the endosomal-lysosomal system. Since the latter is a common pathogenic pathway linking together diseases, such as Alzheimer's and Parkinson's, it might be the focus of future studies aimed to identify new therapeutic targets in neurodegenerative diseases.
Keywords: Genome-wide expression; Human prion; Membrane trafficking; Retromer; Sporadic Creutzfeldt-Jakob disease; VPS35.
Similar articles
-
Subtype-specific synaptic proteome alterations in sporadic Creutzfeldt-Jakob disease.J Alzheimers Dis. 2013;37(1):51-61. doi: 10.3233/JAD-130455. J Alzheimers Dis. 2013. PMID: 23780662
-
Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.Neuropathol Appl Neurobiol. 2015 Aug;41(5):631-45. doi: 10.1111/nan.12175. Epub 2015 Apr 30. Neuropathol Appl Neurobiol. 2015. PMID: 25134744
-
Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis.PLoS Pathog. 2018 Jan 22;14(1):e1006802. doi: 10.1371/journal.ppat.1006802. eCollection 2018 Jan. PLoS Pathog. 2018. PMID: 29357384 Free PMC article.
-
Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies.Int J Mol Sci. 2016 Feb 4;17(2):206. doi: 10.3390/ijms17020206. Int J Mol Sci. 2016. PMID: 26861289 Free PMC article. Review.
-
Clinical findings and diagnostic tests in Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease.Folia Neuropathol. 2004;42 Suppl B:24-38. Folia Neuropathol. 2004. PMID: 16903140 Review.
Cited by
-
The Role of Vesicle Trafficking Defects in the Pathogenesis of Prion and Prion-Like Disorders.Int J Mol Sci. 2020 Sep 23;21(19):7016. doi: 10.3390/ijms21197016. Int J Mol Sci. 2020. PMID: 32977678 Free PMC article. Review.
-
CSF SerpinA1 in Creutzfeldt-Jakob disease and frontotemporal lobar degeneration.Ann Clin Transl Neurol. 2020 Feb;7(2):191-199. doi: 10.1002/acn3.50980. Epub 2020 Jan 20. Ann Clin Transl Neurol. 2020. PMID: 31957347 Free PMC article.
-
Deciphering Copper Coordination in the Mammalian Prion Protein Amyloidogenic Domain.Biophys J. 2020 Feb 4;118(3):676-687. doi: 10.1016/j.bpj.2019.12.025. Epub 2020 Jan 3. Biophys J. 2020. PMID: 31952810 Free PMC article.
-
Identification of recurrent genetic patterns from targeted sequencing panels with advanced data science: a case-study on sporadic and genetic neurodegenerative diseases.BMC Med Genomics. 2022 Feb 10;15(1):26. doi: 10.1186/s12920-022-01173-4. BMC Med Genomics. 2022. PMID: 35144616 Free PMC article.
-
Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study.Lancet Neurol. 2020 Oct;19(10):840-848. doi: 10.1016/S1474-4422(20)30273-8. Epub 2020 Sep 16. Lancet Neurol. 2020. PMID: 32949544 Free PMC article.
References
-
- Golde TE, Borchelt DR, Giasson BI, Lewis J (2013) Thinking laterally about neurodegenerative proteinopathies. J Clin Invest 123:1847–1855. https://doi.org/10.1172/JCI66029 - DOI - PubMed - PMC
-
- Paulson HL (1999) Protein fate in neurodegenerative proteinopathies: Polyglutamine diseases join the (mis)fold. Am J Hum Genet 64:339–345. https://doi.org/10.1086/302269 - DOI - PubMed - PMC
-
- Capellari S, Strammiello R, Saverioni D, Kretzschmar H, Parchi P (2011) Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: Insights into phenotypic variability and disease pathogenesis. Acta Neuropathol 121:21–37. https://doi.org/10.1007/s00401-010-0760-4 - DOI - PubMed
-
- Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, Klug GM, Sutcliffe T et al (2005) Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 64:1586–1591. https://doi.org/10.1212/01.WNL.0000160117.56690.B2 - DOI - PubMed
-
- Brown P, Farrell M (2015) A practical approach to avoiding iatrogenic Creutzfeldt-Jakob disease (CJD) from invasive instruments. Infect Control Hosp Epidemiol 36:844–848. https://doi.org/10.1017/ice.2015.53 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous